A revolutionary gene editing technology, CRISPR, is sparking global debates on its ethics, with a UK entrepreneur now spearheading efforts to 'edit' human embryos. Cathy Tie, the biotech pioneer dubbed 'Biotech Barbie', wants parents to have control over their children's genetic makeup, moving beyond the natural conception process.
The technology at the heart of this vision is CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a powerful gene-editing tool capable of precisely altering DNA sequences. While promising for correcting genetic defects and treating inherited diseases, its application to human embryos raises profound concerns about exacerbating social inequalities, commodifying human life, and unintended long-term consequences.
Under UK law, the regulatory landscape surrounding human embryo research is exceptionally stringent. The Human Fertilisation and Embryology Authority (HFEA) governs all aspects of fertility treatment and embryo research, with strict prohibitions on germline gene editing – modifications that would be passed down to future generations.
The implications for UK businesses and consumers are complex. Advanced reproductive technologies could create new markets in fertility and genetic health but also present significant ethical hurdles and public acceptance challenges. Consumers may welcome the promise of eradicating hereditary diseases, but the spectre of 'genetic haves' and 'have-nots' could deepen societal divides.
Dr Sarah Jones, a UK-based bioethicist, warns that the move towards 'editing' embryos for non-medical reasons is a "dangerous slippery slope". She stresses the need for robust public debate and future-proofed regulatory frameworks to address technologies that fundamentally alter what it means to be human.
The data generated from genetic screening and editing would fall under UK privacy regulations, with the Information Commissioner's Office (ICO) and EU AI Act principles being highly relevant. This highlights the multifaceted challenges facing the industry as well as the need for informed public discourse.